Cost per patient and potential budget implications of denosumab compared with zoledronic acid in adults with bone metastases from solid tumours who are at risk of skeletal-related events: an analysis for Austria, Sweden and Switzerland

Publikation aus Health

Lothgren Mickael, Ribnicsek Erna, Schmidt Louise , Habacher Wolfgang , Lundkvist Jonas, Pfeil Alena M., Biteeva Irina, Vrouchou Polina, Bracco Andrea

European Journal of Hospital Pharmacy-Science and Practice 20(4):227-231, 2013